Mesalamine Capsule, Extended Release
Product Images NDC 0781-2793

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0781-2793). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (250 mg Capsule Bottle Label)

This is a description of Mesalamine Extended-Release Capsules, each containing 250 mg of mesalamine. It is a pharmacy bulk package and should be dispensed in a light-resistant container with a child-resistant closure. The capsules should be stored at 20° to 25°C (68° to 77°F) according to USP guidelines. The manufacturer is Sandoz Inc, located in Princeton, NJ, USA.*

FDA Label Image

Principal Display Panel (500 mg Capsule Bottle Label)

This is a prescription medication called Mesalamine Extended-Release Capsules, USP with a strength of 500 mg. It is supplied in a pack of 120 capsules by SANDOZ. Each capsule contains 500 mg of mesalamine, USP. The dosage and administration information should be read from the package insert. It is important to keep this medication out of the reach of children. The pharmacist should dispense the contents in a proper container and store it at 20° to 25°C (68° to 77°F). The manufacturer is Wi by Fourt (ndi) Laboratore Private Limited, India, and it is distributed by Sandoz Inc, Princeton, NJ.*

FDA Label Image

Chemical Structure (Structure01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.